Future studies addressing patient specific variations of DLK1 and its association to heart disease may be valuable, as is the testing of site‐specific inhibition of DLK1 in the pericardial compartment to avoid potential adverse events systemically. The gene discussed is DLK1; the disease is heart disorder.